The page is the record's research on the issuer — no analyst, no rating, no view. # Aptabio Therapeutics Inc. (KOSDAQ: 293780) — research page As of 2026-11-06 · kr-cm-kg · record version 1 ## Identity and listing The issuer is Aptabio Therapeutics Inc., listed on KOSDAQ under ticker 293780, with ISIN KR7293780003. The LEI is not on the record; no GLEIF record is registered as 135-86-03821. The security type is Corporate, the segment is not on the record, the sector is 자연과학 및 공학 연구개발업, and the jurisdiction is South Korea as a DART filer with a corporate registration number. The issuer is listed and not halted. ## The disclosure read The record holds 29 filings across 24 filing days in the window 2025-11-06 to 2026-11-06. The filings are 4 agm_egm, 19 corporate_news, 1 regulatory_filing and 5 results. The median gap between filing days is 8 days. The record date is 2026-11-06, and the latest filing is dated 2026-10-14, a corporate_news filing, 23 days before the record date. The KOSDAQ median is 33 filings, a median cadence gap of 8.0 days and a median latency of 16.0 days across 1819 issuers. The sector median is 42.5 filings, a median cadence gap of 7 days and a median latency of 15 days across 80 issuers. ## Auditor The auditor of record is 정진세림회계법인. Its location is not on the record. Auditor changes are not on the record. ## Events and halts The listing, delisting, name change, domicile change and segment move lines are not on the record, because no lifecycle type map exists for this register yet. The halt flag shows listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read; the count is 0. ## Open research The record holds 5 openly published research notes: IV Research on 2025-12-22, 상상인증권리서치센터 on 2025-02-24, IV Research on 2025-01-08, 상상인증권리서치센터 on 2021-12-20, and Bookook Research Center on 2020-10-12. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-12. Years 2021 through 2026 are sealed in the store but not served as of a date; the as-of door answers not_sealed. ## Sources 13 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange) - https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin) - https://opendart.fss.or.kr/api/company.json?corp_code=01251595 (identity.jurisdiction) - https://mcp.kr-cm-kg.ai/events/KOSDAQ/293780 (the disclosure lines) - https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag) - https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260323001542 (the auditor) - https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter) - https://aptabio.com/upload/board/information/20251222_073933_138.pdf (open research) - https://aptabio.com/upload/board/information/20250224_100737_363.pdf (open research) - https://aptabio.com/upload/board/information/20250224_105656_425.pdf (open research) - https://aptabio.com/upload/board/information/20250224_102110_567.pdf (open research) - https://aptabio.com/upload/board/information/20250224_101525_627.pdf (open research) - https://mcp.kr-cm-kg.ai/record/KOSDAQ/293780 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/kr/KOSDAQ/293780 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp